title: YAC contigs covering an 8-megabase region of 3p deleted in the small-cell lung cancer cell line U2020.
abstract: Somatic deletions of chromosome 3p occur at high frequencies in cancers of kidney, breast, cervix, head and neck, nasopharynx, and lung. The frequency of 3p deletion in lung cancer approaches 100% among small cell lesions and 70 to 80% in non-small cell lesions. This evidence strongly implies that one or more tumor suppressor genes of potentially widespread significance reside within the deleted region(s). Precise definition of the deleted target region(s) has been difficult due to the extensive area(s) lost and use of markers with low informativeness. However, improved definition remains essential to permit isolation of putative tumor suppressor genes from 3p. The identification of several small, homozygous 3p deletions in lung cancer cell lines has provided a critical resource that will assist this search. The U2020 cell line contains a small homozygous deletion that maps to a very proximal region of 3p and includes the marker D3S3. We previously identified a subset of DNA markers located within the deleted region and determined their relative order by pulsed-field gel mapping studies. In the present report, we describe the development of YAC contigs that span the majority of the deleted region and link up to flanking markers on both sides. The centromere proximal portion of the contig crosses the breakpoint from an X;3 translocation located within 3p12 providing both location and orientation to the map. PCR-based (CA)n microsatellite polymorphisms have been localized within and flanking the deletion region. These markers should greatly facilitate loss-of-heterozygosity studies of this region in human cancer. The contig provides a direct means for isolation of putative tumor suppressor genes from this segment of 3p.
authors.affiliation: Eleanor Roosevelt Institute for Cancer Research, Denver, Colorado 80206, USA.
authors.forename: S
authors.initials: S
authors.lastname: Todd
authors.forename: J
authors.initials: J
authors.lastname: Roche
authors.forename: L
authors.initials: L
authors.lastname: Hahner
authors.forename: R
authors.initials: R
authors.lastname: Bolin
authors.forename: H A
authors.initials: HA
authors.lastname: Drabkin
authors.forename: R M
authors.initials: RM
authors.lastname: Gemmill
mesh_terms: D001483:Base Sequence; D018288:Carcinoma, Small Cell / Q000235:genetics*; D002460:Cell Line; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D018244:Chromosomes, Artificial, Yeast; D002893:Chromosomes, Human, Pair 3; D003001:Cloning, Molecular / Q000379:methods; D017931:DNA Primers; D005819:Genetic Markers; D006801:Humans; D008175:Lung Neoplasms / Q000235:genetics*; D008969:Molecular Sequence Data; D014407:Tumor Cells, Cultured
chemical_list: D017931:DNA Primers; D005819:Genetic Markers